SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041253
Filing Date
2017-06-21
Accepted
2017-06-21 18:11:58
Documents
1
Period of Report
2017-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6620
  Complete submission text file 0001209191-17-041253.txt   8109
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Countouriotis Athena (Reporting) CIK: 0001571469 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 17923677